Fake Drugs & Ghost Doctors

In one line

When medicines are fake or substandard and clinics are staffed only on paper, healthcare becomes a deadly lottery — and the poorest carry the heaviest risk.

1The problem in plain terms

Health-sector corruption has a body count. Spurious or substandard drugs fail to cure — or actively harm. Procurement scams buy expired, overpriced or unneeded supplies. Ghost doctors and staff draw salaries from clinics that are locked or empty when patients arrive.

Unlike most corruption, the cost here is not just money — it is health and life.

2How a fake drug reaches a patient

Weak oversightGaps in inspection & testing

→

Fake supply entersSpurious / substandard batches

→

Sold as genuinePharmacy or hospital stock

→

Patient harmedNo cure, resistance, or death

The patient often never learns why the treatment failed.

3Know the difference

Five threats inside the health system
Term	What it means	The danger
Substandard	Genuine maker, but fails quality limits	Too weak to cure; builds resistance
Spurious / falsified	Fake origin or contents, deliberately mislabelled	May contain nothing — or poison
Counterfeit	Copies a real brand’s packaging	Bypasses all safety checks
Procurement scam	Expired/overpriced stock bought on kickback	Public funds lost; shortages of real drugs
Ghost doctor	Paid post, but never present	No care where it is needed most

4Where the harm lands

Rural / remote clinicsHighest risk

Low-income patientsVery high risk

Emergency & chronic careHigh risk

Well-monitored hospitalsLower risk

Those with the fewest options — the rural poor, the chronically ill — are the ones most exposed to a counterfeit drug or an empty clinic.

5How to spot it

No batch number, expiry or manufacturer details, or packaging that looks slightly ‘off’.
A medicine priced far below the usual market rate.
A government clinic that is locked in working hours while staff remain on the payroll.
Treatment that repeatedly fails with no medical explanation.

6What can be done

Track-and-trace barcodes / QR so any buyer can verify a medicine’s origin.
Stronger drug-regulator (DRAP) testing and enforcement, with public results.
Biometric attendance for health staff tied to pay.
Citizen reporting lines for fake drugs and absent staff.
Open procurement records showing what was bought, at what price, from whom.

This report is an educational explainer. It describes how this form of corruption generally works and how it can be reduced. It is not an allegation against any specific person or institution. Figures are illustrative unless cited.